Cleared Traditional

K860999 - GILFORD UNIQUAL ABNORMAL CONTROL SERUM/...

K860999 is an FDA 510(k) clearance for GILFORD UNIQUAL ABNORMAL CONTROL SERUM/..., manufactured by Ciba Corning Diagnostics Corp.. The device is a Class 1 Chemistry device with product code JJY cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K860999 · Ciba Corning Diagnostics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1986
Decision
106d
Days
Class 1
Risk

K860999 is an FDA 510(k) clearance for the GILFORD UNIQUAL ABNORMAL CONTROL SERUM/ASSAYED. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Ciba Corning Diagnostics Corp. (East Walpole, US). The FDA issued a Cleared decision on July 2, 1986 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Ciba Corning Diagnostics Corp. devices

FDA 510(k) Submission Details - K860999

510(k) Number K860999 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1986
Decision Date July 02, 1986
Days to Decision 106 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d slower than avg
Panel avg: 88d · This submission: 106d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 515
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K860999.
QUANTIMETRIX DRUG FREE HUMAN URINE CONTROL
K861420 · Quantimetrix Corp. · Sep 1986
THERAPEUTIC DRUG MONITORING CONTROL SET
K862963 · American Monitor Corp. · Sep 1986
LYPHOCHEK PEDIATRIC AND BILIRUBIN CONTROL
K862185 · Bio-Rad · Aug 1986
STRATUS IMMUNOASSAY CONTROLS, LEVELS I, II, III
K860906 · American Dade · May 1986
QUANTIMETRIX HUMAN BILIRUBIN CONTROL I & II LIQUID
K860942 · Quantimetrix Corp. · May 1986
THERACHEM-PLUS, TRI-LEVEL TDC (TM)
K861185 · Fisher Scientific Co., LLC · May 1986